Skip to main content

Advertisement

SpringerLink
Log in

Indirect comparison of etanercept, infliximab, and adalumimab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator

  • Letter to the Editor
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ (2000) Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356:385–390

    Article  PubMed  CAS  Google Scholar 

  2. Antoni CE, Kavanaugh A, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman D, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, Kalden JR, Smolen J (2005) Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT). Arthritis Rheum 52(4):1227–36. Erratum in. Arthritis Rheum 52(9):2951

    CAS  Google Scholar 

  3. Antoni C, Krueger GG, de Vlam K, Birbara C, Beutler A, Guzzo C, Zhou B, Dooley LT, Kavanaugh A (2005) IMPACT 2 Trial Investigators. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 64(8):1150–1157

    Article  PubMed  CAS  Google Scholar 

  4. Genovese MC, Mease PJ, Thomson GT, Kivitz AJ, Perdok RJ, Weinberg MA, Medich J, Sasso EH (2007) Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy. J Rheumatol 34(5):1040–1050

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology, S. Pietro FBF Hospital, Rome, Italy

    Alberto Migliore & Emanuele Bizzi

  2. CRO, Bioikos Pharma, Bologna, Italy

    Serena Broccoli

  3. Rheumatology, 2nd medical school, La Sapienza University, Rome, Italy

    Bruno Laganà

Authors
  1. Alberto Migliore
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emanuele Bizzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Serena Broccoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bruno Laganà
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emanuele Bizzi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Migliore, A., Bizzi, E., Broccoli, S. et al. Indirect comparison of etanercept, infliximab, and adalumimab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator. Clin Rheumatol 31, 193–194 (2012). https://doi.org/10.1007/s10067-011-1862-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-011-1862-7

Keywords

Search

Navigation